Skip to content
10-K

Annual Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000822

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents FY 2020 · Sep 30, 2020 $0
Current Liabilities FY 2020 · Sep 30, 2020 $250.5K
Current Liabilities FY 2020 · Sep 30, 2019 $235.61K
Current Assets FY 2020 · Sep 30, 2020 $408
Current Assets FY 2020 · Sep 30, 2019 $527
Operating Cash Flow FY 2020 · Sep 30, 2019 −$1.74K
Total Liabilities FY 2020 · Sep 30, 2019 $235.61K
Total Assets FY 2020 · Sep 30, 2019 $527
Net Income FY 2020 · Sep 30, 2019 −$13.99K
Operating Income FY 2020 · Sep 30, 2019 −$5.68K
Stockholders Equity FY 2020 · Sep 30, 2018 −$221.09K